Remove Finance Remove Innovation Remove Pharmaceuticals Remove Scenario Planning
article thumbnail

What a Changing NAFTA Could Mean for Doing Business in Mexico

Harvard Business Review

Firms in innovation-driven industries, such as pharmaceuticals and medical devices, have long supported greater standardization across borders, with stronger intellectual property protections and enforcement of regulatory standards. Navigating the Next Two Years in Mexico.